18724359 |
Identification of ALK as a major familial neuroblastoma predisposition gene
Hakonarson, H,
Kim, C,
Speleman, F,
Laureys, G,
Mossé, YP,
Hou, C,
Schork, NJ,
Maris, JM,
Tonini, GP,
Devoto, M,
Attiyeh, EF,
Rappaport, E,
Laudenslager, M,
Cole, KA,
Wood, A,
Lynch, JE,
Sennett, R,
Laquaglia, MJ,
Longo, L,
Torkamani, A,
Perri, P,
Brodeur, GM
|
Nature |
2008 |
24356251 |
ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
Nafady, A,
Ohira, M,
Nakamura, Y,
Akter, J,
Hossain, S,
Hasan, MK,
Ogura, A,
Takatori, A,
Nakagawara, A,
Kadomatsu, K,
Suenaga, Y,
Kishida, S
|
Sci Rep |
2013 |
24947326 |
Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells
Sommer, L,
Delattre, O,
Jauquier, N,
Coulon, A,
Peuchmaur, M,
Bourloud, KB,
Flahaut, M,
Yan, P,
Mühlethaler-Mottet, A,
Janoueix-Lerosey, I,
Joseph, JM,
Montavon, G,
Gross, N
|
Oncotarget |
2014 |
22439933 |
Activated ALK collaborates with MYCN in neuroblastoma pathogenesis
George, RE,
Rodig, SJ,
Shin, J,
Zhu, S,
Helman, D,
Kanki, JP,
Stewart, RA,
Wang, W,
Lee, JS,
Look, AT,
Feng, H,
Neuberg, DS,
Guo, F,
Kutok, JL,
Pérez-Atayde, AR
|
Cancer Cell |
2012 |
20719933 |
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification
Laureys, G,
Cools, J,
Eggert, A,
Caron, H,
Renard, M,
Lakeman, A,
Porcu, M,
Van Maerken, T,
De Brouwer, S,
Westerhout, EM,
Schulte, JH,
Janoueix-Lerosey, I,
Vandesompele, J,
Ohira, M,
Speleman, F,
De Preter, K,
Vermeulen, J,
Versteeg, R,
Zabrocki, P,
Kumps, C,
Nakagawara, A,
Hoebeeck, J,
Van Roy, N,
Schramm, A,
Noguera, R,
Beiske, K,
Delattre, O,
De Paepe, A,
Kogner, P,
Martinsson, T,
Van den Broecke, C
|
Clin Cancer Res |
2010 |
18990089 |
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Abel, F,
Carén, H,
Kogner, P,
Martinsson, T
|
Biochem J |
2008 |
23201355 |
Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition
Roskoski, R
|
Pharmacol. Res. |
2013 |
22286764 |
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
Wang, CL,
Hallberg, B,
Kamaraj, S,
Martinsson, T,
Palmer, RH,
Yang, HL,
Ruuth, K,
Combaret, V,
Christensen, JG,
Schönherr, C,
Djos, A
|
Oncogene |
2012 |
24060861 |
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Palmer, RH,
Hallberg, B
|
Nat. Rev. Cancer |
2013 |